Home » Stocks » GMVD

G Medical Innovations Holdings Ltd. (GMVD)

G Medical Innovations will go public soon, but the exact IPO date is still unknown.
Stock Price: $5.00 - $7.00
Current IPO price range

Stock Price Chart

Key Info

Market Cap 358.63M
Revenue (ttm) 4.63M
Net Income (ttm) -13.07M
Shares Out 59.77M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

More Stats

Market Cap 358.63M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 59.77M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.22
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield -3.64%
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 77.49
PB Ratio n/a
Revenue 4.63M
Operating Income n/a
Net Income -13.07M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin -282.43%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth80.47%-
Net Income / Loss-15.01-16.26
Numbers in millions USD.

Company Profile

Company Details

Full Name G Medical Innovations Holdings Ltd.
Country Israel
Employees 72
CEO Yacov Geva

Stock Information

Ticker Symbol GMVD
Stock Exchange NASDAQ
Industry Surgical & Medical Instruments & Apparatus
Unique Identifier NASDAQ: GMV
IPO Date Pending


G Medical Innovations is an early commercial stage healthcare company engaged in the development of next generation mobile health (or mHealth) and telemedicine solutions and monitoring service platforms. We believe we are at the forefront of the digital health revolution in developing the next generation mobile technologies and services that are designed to empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes. Using our proprietary and patented suite of devices, software solutions, algorithms and monitoring services, we intend to drive recurring revenue streams in two vertical markets, with a focus on markets in the United States and China as well as other markets: Business to business (or B2B): professional healthcare markets (including hospitals, clinics and senior care facilities); and Business to business to consumer (or B2B2C) and business to consumer (or B2C): consumer healthcare markets.